INSUPATCH Trademark

Trademark Overview

On Monday, January 5, 2009, a trademark application was filed for INSUPATCH with the United States Patent and Trademark Office. The USPTO has given the INSUPATCH trademark a serial number of 77643488. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 29, 2019. This trademark is owned by InsuLine Medical Ltd.. The INSUPATCH trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for the delivery of a medicament such as insulin, insulin mimetic, hormones, glucagon and analgesics; Transdermal drug delivery patch or pad for assisting the delivery of at least one or more doses of a medicament or of insulin, insulin mimetic, hormones, glucagon and analgesics sold without medication; Transdermal drug delivery patch or pad in use with an infusion pump or drug delivery device for the subcutaneous drug delivery of at least one or more doses of a medicament or of insulin, insulin mimetic, hormones, glucagon and analgesics sold without medication
insupatch

General Information

Serial Number77643488
Word MarkINSUPATCH
Filing DateMonday, January 5, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 29, 2019
Registration Number4324642
Registration DateTuesday, April 23, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2009

Trademark Statements

Goods and ServicesMedical devices for the delivery of a medicament such as insulin, insulin mimetic, hormones, glucagon and analgesics; Transdermal drug delivery patch or pad for assisting the delivery of at least one or more doses of a medicament or of insulin, insulin mimetic, hormones, glucagon and analgesics sold without medication; Transdermal drug delivery patch or pad in use with an infusion pump or drug delivery device for the subcutaneous drug delivery of at least one or more doses of a medicament or of insulin, insulin mimetic, hormones, glucagon and analgesics sold without medication
Pseudo MarkINSULIN PATCH; INSULINE PATCH

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 29, 2019
Primary Code010
First Use Anywhere DateMonday, August 31, 2009
First Use In Commerce DateMonday, August 31, 2009

Trademark Owner History

Party NameInsuLine Medical Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPetach-Tikvah 49002
IL
Party NameInsuLine Medical Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPetach-Tikvah 49002
IL
Party NameInsuLine Medical Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPetach-Tikvah 49002
IL

Trademark Events

Event DateEvent Description
Friday, November 29, 2019CANCELLED SEC. 8 (6-YR)
Monday, April 23, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 15, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 15, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, March 20, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 19, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, March 18, 2013ASSIGNED TO LIE
Wednesday, March 6, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 26, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 26, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 25, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, February 22, 2013USE AMENDMENT FILED
Friday, February 22, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 22, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, August 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2012EXTENSION 5 GRANTED
Tuesday, August 21, 2012EXTENSION 5 FILED
Tuesday, August 21, 2012TEAS EXTENSION RECEIVED
Saturday, February 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 24, 2012EXTENSION 4 GRANTED
Monday, February 20, 2012EXTENSION 4 FILED
Monday, February 20, 2012TEAS EXTENSION RECEIVED
Tuesday, August 30, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 29, 2011EXTENSION 3 GRANTED
Tuesday, August 23, 2011EXTENSION 3 FILED
Tuesday, August 23, 2011TEAS EXTENSION RECEIVED
Saturday, March 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2011EXTENSION 2 GRANTED
Monday, February 21, 2011EXTENSION 2 FILED
Friday, March 4, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 21, 2011TEAS EXTENSION RECEIVED
Tuesday, February 15, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2010EXTENSION 1 GRANTED
Monday, August 23, 2010EXTENSION 1 FILED
Monday, August 23, 2010TEAS EXTENSION RECEIVED
Tuesday, February 23, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2009PUBLISHED FOR OPPOSITION
Thursday, October 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 29, 2009ASSIGNED TO LIE
Thursday, October 15, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 25, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 25, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 25, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2009NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, March 27, 2009PRIORITY ACTION E-MAILED
Friday, March 27, 2009PRIORITY ACTION WRITTEN
Friday, March 20, 2009ASSIGNED TO EXAMINER
Friday, January 9, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, January 8, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

insupatch insulin delivery drug glucagon medicament hormones analgesics mimetic medication least